Article
TRAF3IP2 mediates atherosclerotic plaque development and vulnerability in ApoE(-/-) mice.
Atherosclerosis - 1 Sept 2016
Sakamuri Siva Sankara Vara Prasad, Higashi Yusuke, Sukhanov Sergiy, Siddesha Jalahalli M, Delafontaine Patrice, Siebenlist Ulrich, Chandrasekar Bysani
Abstract excerpt
BACKGROUND AND AIMS: Atherosclerosis is a major cause of heart attack and stroke. Inflammation plays a critical role in the development of atherosclerosis. Since the cytoplasmic adaptor molecule TRAF3IP2 (TRAF3-Interacting Protein 2) plays a causal role in various autoimmune and inflammatory diseases, we hypothesized that TRAF3IP2 mediates atherosclerotic plaque development. METHODS: TRAF3IP2/ApoE double knockout...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
